Histogenics (HSGX) Misses Q1 EPS by 1c
Tweet
Share
E-mailGet Alerts HSGX Hot Sheet
Join SI Premium – FREE
Histogenics (NASDAQ: HSGX) reported Q1 EPS of ($0.60), $0.01 worse than the analyst estimate of ($0.59).
For earnings history and earnings-related data on Histogenics (HSGX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Upgrades Aviva Plc (AV/:LN) (AIVAF) to Overweight
- ArriVent BioPharma, Inc. (AVBP) Misses Q2 EPS by 13c
- Capstone Energy+, Inc. (CEPL) Reports Q2 Loss of $0.03
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
